Evariste

Evariste is a drug discovery company developing small-molecule inhibitors of synthetic lethal targets in cancer.

Its computational platform combines machine learning, multimodal biological data and molecular modelling to identify therapeutic targets, design candidate compounds and prioritise laboratory testing. The company advances preclinical programmes against vulnerabilities in tumour cells, including targets associated with replication stress and altered kinase activity, and collaborates with research and pharmaceutical partners on molecule discovery.